NEW YORK, Feb. 21 (GenomeWeb News) - Carna Biosciences has acquired the exclusive worldwide rights to sell CrystalGenomics' kinase crystallization-related products and services, the companies said today.

Specific terms of the deal were not disclosed.

Carna, which is based in Japan, and CrystalGenomics, which is based on Korea, have been jointly researching kinase inhibitors since forming an alliance in June 2004.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.